LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 199 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,292 | -16.9% | 105 | 0.0% | 0.00% | – |
| Q2 2023 | $7,571 | -27.5% | 105 | -26.1% | 0.00% | – |
| Q1 2023 | $10,446 | +10.1% | 142 | 0.0% | 0.00% | – |
| Q4 2022 | $9,486 | -21.0% | 142 | +3.6% | 0.00% | – |
| Q3 2022 | $12,000 | +33.3% | 137 | +37.0% | 0.00% | – |
| Q2 2022 | $9,000 | -30.8% | 100 | -13.8% | 0.00% | – |
| Q1 2022 | $13,000 | -27.8% | 116 | +0.9% | 0.00% | -100.0% |
| Q4 2021 | $18,000 | +12.5% | 115 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $16,000 | -23.8% | 115 | -28.6% | 0.00% | 0.0% |
| Q2 2021 | $21,000 | 0.0% | 161 | +14.2% | 0.00% | 0.0% |
| Q1 2021 | $21,000 | +40.0% | 141 | -4.1% | 0.00% | 0.0% |
| Q4 2020 | $15,000 | -21.1% | 147 | -26.9% | 0.00% | 0.0% |
| Q3 2020 | $19,000 | -9.5% | 201 | +5.2% | 0.00% | 0.0% |
| Q2 2020 | $21,000 | +950.0% | 191 | +730.4% | 0.00% | – |
| Q1 2020 | $2,000 | -99.0% | 23 | -96.9% | 0.00% | -100.0% |
| Q3 2018 | $206,000 | – | 750 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |